Skip to main content
SpringerLink
Log in

Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To investigate the mechanism of inflflammatory-mediated toll-like receptor 4 (TLR4)-p38 mitogen-activated protein kinase (p38 MAPK) pathway in Kupffer cells (KCs) of non-alcoholic steatohepatitis (NASH) rats and the intervention effect of soothing Gan (Liver) and invigorating Pi (Spleen) recipes on this pathway.

Methods

After 1 week of acclimatization, 120 Sprague-Dawley male rats were randomly divided into 8 groups using a random number table (n=15 per group): normal group, model group, low-dose Chaihu Shugan Powder (柴胡疏肝散, CHSG) group (3.2 g/kg), high-dose CHSG group (9.6 g/kg), low-dose Shenling Baizhu Powder (参苓白术散, SLBZ) group (10 g/kg), high-dose SLBZ (30 g/kg) group, and low- and highdose integrated recipe (L-IR, H-IR) groups. All rats in the model and treatment groups were fed with a high-fat diet (HFD). The treatments were administrated by gastrogavage once daily and lasted for 26 weeks. The liver tissues were detected with hematoxylin-eosin (HE) and oil red O staining. Levels of liver lipids, serum lipids and transaminases were measured. KCs were isolated from the livers of rats to evaluate the mRNA expressions of TLR4 and p38 MAPK by real-time flfluorescence quantitative polymerase chain reaction, and proteins expressions of TLR4, p-p38 MAPK and p38 MAPK by Western blot. Levels of inflammatory cytokines including tumor necrosis factor α (TNF-α), interleukin (IL)-1 and IL-6 in KCs were measured by enzyme-linked immunosorbent assay.

Results

After 26 weeks of HFD feeding, HE and oil red O staining showed that the NASH model rats successfully reproduced typical pathogenesis and histopathological features. Compared with the normal group, the model group exhibited significant increases in body weight, liver weight, liver index, serum levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol, and aspartate aminotransferase as well as TC and TG levels in liver tissues, and significant decrease in serum level of high-density lipoprotein cholesterol (Plt;0.05 or Plt;0.01), while those indices were significantly ameliorated in the H-IR group (Plt;0.05 or Plt;0.01). Higher levels of TNF-α, IL-1 and IL-6 in KCs were observed in the model group compared with the normal group (Plt;0.01). Significant decreases in TNF-α, IL-1 and IL-6 were observed in the H-SLBZ, H-IR and L-IR groups compared with the model group (Plt;0.05 or Plt;0.01). The mRNA expressions of TLR4 and p38 MAPK and protein expressions of TLR4, p38 MAPK and p-p38 MAPK in KCs in the model group were significantly higher than the normal group (Plt;0.01), while those expression levels in the L-IR and H-IR groups were significantly lower than the model group (Plt;0.05 or Plt;0.01).

Conclusion

Inflflammation in KCs might play an important role in the pathogenesis of NASH in rats. The data demonstrated the importance of TLR4-p38MAPK signaling pathway in KCs for the anti-inflflammatory effect of soothing Gan and invigorating Pi recipes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ritze Y, Böhle M, Haub S, Hubert A, Enck P, Zipfel S, et al. Role of serotonin in fatty acid–induced non–alcoholic fatty liver disease in mice. BMC Gastroenterol 2013;13:169.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non–alcoholic fatty liver disease and non–alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274–285.

    Article  PubMed  CAS  Google Scholar 

  3. Korish AA, Arafah MM. Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non–alcoholic fatty liver disease. BMC Complement Altern Med 2013;13:264.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE. From NAFLD to NASH to cirrhosis—new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol 2013;10:627–636.

    Article  PubMed  CAS  Google Scholar 

  5. De Wit NJ, Afman LA, Mensink M. Phenotyping the effect of diet on non–alcoholic fatty liver disease. J Hepatol 2012;57:1370–1373.

    Article  PubMed  CAS  Google Scholar 

  6. Mukundh NB, Muralidharan P, Balamurugan G. Antihyperlipidemic activity of Pedalium murex (Linn) fruits on high fat diet fed rats. Int J Pharmacol 2008;4:310–313.

    Article  Google Scholar 

  7. Yang QH, Xu YJ, Feng GF, Hu CF, Zhang YP, Cheng SB, et al. p38 MAPK signal pathway involved in antiinflammatory effect of Chaihu–shugan–san and Shen–lingbai–zhu–san on hepatocyte in non–alcoholic steatohepatitis rats. Afr J Tradit Complement Altern Med 2013;11:213–221.

    PubMed  PubMed Central  Google Scholar 

  8. Tomeno W, Yoneda M, Imajo K, Ogawa Y, Kessoku T, Saito S, et al. Emerging drugs for non–alcoholic steatohepatitis. Expert Opin Emerg Drugs 2013;18:279–290.

    Article  PubMed  CAS  Google Scholar 

  9. Li ZZ, Xue J, Chen P, Chen L, Yan S, Liu L. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta–analysis of published studies. J Gastroenterol Hepatol 2014;29:42–51.

    Article  PubMed  CAS  Google Scholar 

  10. Yang QH, Lin JS, Ping HH, Wen CY. Thinking and countermeasures of prevention and treatment of nonalcoholic fatty liver disease in traditional Chinese medicine. J Tradit Chin Med (Chin) 2007;48:746–748.

    Google Scholar 

  11. Li YQ, Yang QH, Xie WN, Ji GY. Clinical study on soothing Liver and invigorating Spleen method in treating of nonalcoholic fatty liver disease in 35 cases. J Tradit Chin Med (Chin) 2007;48:824–825.

    Google Scholar 

  12. Yang QH, Xu YJ, Liu YZ, Liang YJ, Feng GF, Zhang YP, et al. Effects of Chaihu–Shugan–San and Shen–Ling–Bai–Zhu–San on p38 MAPK pathway in Kupffer cells of nonalcoholic steatohepatitis. Evid Based Complement Alternat Med 2014;2014:671013.

    PubMed  PubMed Central  Google Scholar 

  13. Shi XY, ed. Experimental zoology of modern medicine. Beijing: People’s Military Medical Press;2000:334.

    Google Scholar 

  14. Yang QH, Hu SP, Zhang YP, Ping HH, Yang HW, Chen TY, et al. Effects of different therapeutic methods and typical recipes of Chinese medicine on activation of c–Jun N–terminal kinase in Kupffer cells of rats with fatty liver disease. Chin J Integr Med 2012;18:769–774.

    Article  PubMed  Google Scholar 

  15. Feng GF, Yang QH, Wang WJ, He XM, Zhang YP, Ji GY, et al. Simultaneously isolation and identification of hepatocytes and Kupffer cells from nonalcoholic steatohepatitis rat. Guangdong Med J (Chin) 2012;33:40–43.

    Google Scholar 

  16. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science 2011;332:1519–1523.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Fuchs M. Non–alcoholic fatty liver disease: the bile acidactivated farnesoid x receptor as an emerging treatment target. J Lipids 2012;2012:934–396.

    Article  CAS  Google Scholar 

  18. Nseir W, Mahamid M. Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review. Curr Atheroscler Rep 2013;15:1–6.

    Article  CAS  Google Scholar 

  19. Liaskou E, Wilson DV, Oo YH. Innate immune cells in liver inflammation. Mediators Inflamm 2012;2012:949157.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11:723–737.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol 2012;19;3:56.

    Google Scholar 

  22. Gao B. Cytokines, STATs and liver disease. Cell Mol Immunol 2005;2:92–100.

    PubMed  CAS  Google Scholar 

  23. Papackova Z, Palenickova E, Dankova H, Zdychova J, Skop V, Kazdova L, et al. Kupffer cells ameliorate hepatic insulin resistance induced by high–fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages. Nutr Metab 2012;9:22.

    Article  CAS  Google Scholar 

  24. Farrell GC, van Rooyen D, Gan L, Chitturi S. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 2012;6:149–171.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Yang QH, Xu YJ, Feng GF, Hu CF, Zhang YP, Cheng SB, et al. p38 MAPK signal pathway involved in antiinflammatory effect of Chaihu–shugan–san and Shen–lingbai–zhu–san on hepatocyte in non–alcoholic steatohepatitis rats. Afr J Tradit Complement Altern Med 2014;11:213–221.

    Article  PubMed  Google Scholar 

  26. Fei ZW, Zhang XP, Zhang J, Huang XM, Wu DJ, Bi HH. Protective effects of Radix Astragali Injection on multiple organs of rats with obstructive jaundice. Chin J Integr Med 2016;22:674–684.

    Article  PubMed  Google Scholar 

  27. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004;16:3–9.

    Article  PubMed  CAS  Google Scholar 

  28. Liu Y, Zhang Z, Wang L, Li J, Dong L, Yue W, et al. TLR4 monoclonal antibody blockade suppresses dextran–sulfatesodium–induced colitis in mice. J Gastroenterol Hepatol 2010;25:209–214.

    Article  PubMed  CAS  Google Scholar 

  29. Alisi A, Panera N, Nobili V. Toll–like receptor 4: a starting point for proinflammatory signals in fatty liver disease. Hepatology 2010;51:714–715.

    Article  PubMed  Google Scholar 

  30. Luo JK, Zhou HJ, Wu J, Tang T, Liang QH. Electroacupuncture at Zusanli (ST 36) accelerates intracerebral hemorrhage–induced angiogenesis in rats. Chin J Integr Med 2013;19:367–373.

    Article  PubMed  CAS  Google Scholar 

  31. Qiao NL, Yang QH, Ji GY. A discussion on the view that Liver qi stagnation and Spleen deficiency is the basic pathogenesis of fatty liver. Lishizhen Med Mater Med Res (Chin) 2008;153:1238–1239.

    Google Scholar 

  32. Wei HF, Xin LJ. Preliminary research on nonalcoholic fatty liver syndrome classification. Liaoning J Tradit Chin Med (Chin) 2002;29:655–656.

    Google Scholar 

  33. Zhang SS, Li QG, Li JX. Diagnosis and treatment of traditional Chinese medicine consensus on nonalcoholic fatty liver disease. Beijing J Tradit Chin Med (Chin) 2011;30:83–86.

    Article  Google Scholar 

  34. Li L, Su DM, Han HX, Li JX. Traditional Chinese medicine for non–alcoholic steatohepatitis: a systematic review. Chin J Evid Based Med (Chin) 2011;11:195–203.

    Google Scholar 

  35. Ding T. Shenlingbaizhu Powder of ginseng saponin content determination. Chin J Basic Med Tradit Chin Med (Chin) 2012;10:1134–1135.

    Google Scholar 

  36. Wang CY, Zhang DS, Zhang WM, Guo CY, Xue GP. Determination of four effective components in Chaihu Shugan Powder by HPLC/DAD. Chin Tradit Patent Med (Chin) 2010;32:422–425.

    CAS  Google Scholar 

  37. Wang SL, Jia W, Gao XL. HPLC characteristics of aqueous extract of Chaihu Shugan Powder and determination of markers. Chin Tradit Patent Med (Chin) 2012;34:2384–2388.

    CAS  Google Scholar 

  38. Gong XW, Yang QH, Xu YJ. The effectiveness and safety of soothing Liver and activating Spleen method treating nonalcoholic fatty liver disease. Chin J Gerontol (Chin) 2014;14:3817–3820.

    Google Scholar 

  39. Gong XW, Yang QH, Xu YJ, Huang J. Medication rule for treating Liver depression and Spleen deficiency of fatty liver disease based on data mining. Chin J Exp Tradit Med Formul (Chin) 2013;19:344–348.

    Google Scholar 

  40. Li YQ, Yang QH, Xie WN, Ji GY. 35 patients with nonalcoholic fatty liver treatment of soothing Liver and invigorating Spleen method. J Tradit Chin Med (Chin) 2007;48:824–825.

    Google Scholar 

  41. Yang QH, Ou J, Sun SY, Qiao NL, Chen SB, Chen WQ, et al. Effects of soothing Liver and invigorating Spleen recipes on expression of PI3K p85α protein in hepatocyte of rats with non–alcoholic fatty liver disease. J Guangdong Pharmaceutical Coll (Chin) 2009;25:62–67.

    Google Scholar 

  42. Gong XW, Han L, Yang QH, Yan HZ, Zhang YP, Li YY, et al. Effects of soothing Liver and invigorating Spleen recipe on lipid metabolism disorders in Kupffer cells of NAFLD rats by LXRα/SREBP–1c signal pathway. Chin Herb Med 2014;6:297–304.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Chinese Medicine, Jinan University, Guangzhou, 510632, China

    Xiang-wen Gong, Yong-jian Xu, Qin-he Yang, Yin-ji Liang, Yu-pei Zhang, Guan-long Wang & Yuan-yuan Li

Authors
  1. Xiang-wen Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yong-jian Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qin-he Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yin-ji Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu-pei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guan-long Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuan-yuan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qin-he Yang.

Additional information

Supported by the National Natural Science Foundation of China (No. 30973694)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gong, Xw., Xu, Yj., Yang, Qh. et al. Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats. Chin. J. Integr. Med. 25, 216–224 (2019). https://doi.org/10.1007/s11655-018-2829-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-018-2829-6

Keywords

Search

Navigation